Novo Nordisk Accelerates Drug Discovery with AWS AI, Launches US Weekly Insulin Awiqli
Discover how Novo Nordisk’s AWS AI partnership and U.S. launch of Awiqli drive drug‑discovery speed and shareholder value, reshaping the diabetes‑obesity market.
3 minutes to read